Lower Respiratory Tract Infection Clinical Trials

3 recruiting

Lower Respiratory Tract Infection Trials at a Glance

7 actively recruiting trials for lower respiratory tract infection are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Nashville, Philadelphia, and Dallas. Lead sponsors running lower respiratory tract infection studies include Eduardo Lopez -Medina, Laboratorio Farmaceutico SIT srl, and Ansun Biopharma, Inc..

Browse lower respiratory tract infection trials by phase

About Lower Respiratory Tract Infection Clinical Trials

Looking for clinical trials for Lower Respiratory Tract Infection? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lower Respiratory Tract Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lower Respiratory Tract Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Reducing Overuse of Antibiotics With Decision Support

AsthmaPneumoniaLower Respiratory Tract Infection+1 more
Vanderbilt University Medical Center2,800 enrolled3 locationsNCT06788093
Recruiting
Not Applicable

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

Lower Respiratory Tract Infection
MeMed Diagnostics Ltd.1,316 enrolled10 locationsNCT05762302
Recruiting
Phase 4

Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).

Respiratory InfectionLower Respiratory Tract Infection (LRTI)
Laboratorio Farmaceutico SIT srl240 enrolled10 locationsNCT06736288
Recruiting

Respiratory Infections in Young Children

Respiratory Tract Infections (RTI)Lower Respiratory Tract Infection (LRTI)
Eduardo Lopez -Medina1,088 enrolled2 locationsNCT07249996
Recruiting
Phase 3

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting

Implementation of a strategy to facilitate effective medical follow-up for Australian First Nations children hospitalised with chest infections: study protocol

No routine medical follow up for at-risk children, i.e., First Nations childrenLack of culturally secure health information given to First Nations familiesAcute lower respiratory tract infection
Telethon Kids Institute400 enrolled4 locationsACTRN12622000224729
Recruiting
Phase 4

A pilot study of hypertonic saline in children with chest infections and disabilities

Acute lower respiratory tract infectionsSevere neurological impairment
Paediatric Intensive Care Unit, Royal Children's Hospital Melbourne10 enrolled1 locationACTRN12615000766516